ReviewFrontiers in pharmacology2026

From albuminuria to multi-omics signatures: emerging biomarkers and drug targets for early-stage chronic kidney disease.

Kaili Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.